• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SCHEDULE 13G/A filed by Chemours Company

    8/8/25 4:08:39 PM ET
    $CC
    Major Chemicals
    Industrials
    Get the next $CC alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    (Amendment No. 1)


    The Chemours Company

    (Name of Issuer)


    Common Stock, par value $0.01 per share

    (Title of Class of Securities)


    163851108

    (CUSIP Number)


    06/30/2025

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox not checked   Rule 13d-1(b)
    Checkbox checked   Rule 13d-1(c)
    Checkbox not checked   Rule 13d-1(d)






    SCHEDULE 13G

    CUSIP No.
    163851108


    1Names of Reporting Persons

    Millennium Management LLC
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    7,443,038.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    7,576,095.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    7,576,095.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    5.1 %
    12Type of Reporting Person (See Instructions)

    OO


    SCHEDULE 13G

    CUSIP No.
    163851108


    1Names of Reporting Persons

    Millennium Group Management LLC
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    7,443,038.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    7,576,095.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    7,576,095.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    5.1 %
    12Type of Reporting Person (See Instructions)

    OO


    SCHEDULE 13G

    CUSIP No.
    163851108


    1Names of Reporting Persons

    Israel A. Englander
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    UNITED STATES
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    7,443,038.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    7,576,095.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    7,576,095.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    5.1 %
    12Type of Reporting Person (See Instructions)

    IN


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    The Chemours Company
    (b)Address of issuer's principal executive offices:

    1007 Market Street, Wilmington, Delaware 19801
    Item 2. 
    (a)Name of person filing:

    Millennium Management LLC Millennium Group Management LLC Israel A. Englander
    (b)Address or principal business office or, if none, residence:

    Millennium Management LLC 399 Park Avenue New York, New York 10022 Millennium Group Management LLC 399 Park Avenue New York, New York 10022 Israel A. Englander c/o Millennium Management LLC 399 Park Avenue New York, New York 10022
    (c)Citizenship:

    Millennium Management LLC - Delaware Millennium Group Management LLC - Delaware Israel A. Englander - United States
    (d)Title of class of securities:

    Common Stock, par value $0.01 per share
    (e)CUSIP No.:

    163851108
    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox not checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox not checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox not checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox not checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox not checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox not checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox not checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    Item 4.Ownership
    (a)Amount beneficially owned:

    See response to Item 9 on each cover page. The reporting persons ceased to be beneficial owners of more than 5% of the outstanding Common Stock as of July 1, 2025.
    (b)Percent of class:

    See response to Item 11 on each cover page.
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    See response to Item 5 on each cover page.

     (ii) Shared power to vote or to direct the vote:

    See response to Item 6 on each cover page.

     (iii) Sole power to dispose or to direct the disposition of:

    See response to Item 7 on each cover page.

     (iv) Shared power to dispose or to direct the disposition of:

    See response to Item 8 on each cover page. The securities disclosed herein as potentially beneficially owned by Millennium Management LLC, Millennium Group Management LLC and Mr. Englander are held by entities subject to voting control and investment discretion by Millennium Management LLC and/or other investment managers that may be controlled by Millennium Group Management LLC (the managing member of Millennium Management LLC) and Mr. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). The foregoing should not be construed in and of itself as an admission by Millennium Management LLC, Millennium Group Management LLC or Mr. Englander as to beneficial ownership of the securities held by such entities.

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Checkbox checked    Ownership of 5 percent or less of a class
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    Not Applicable
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    Not Applicable
    Item 8.Identification and Classification of Members of the Group.
     
    If a group has filed this schedule pursuant to §240.13d-1(b)(1)(ii)(J), so indicate under Item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to §240.13d-1(c) or §240.13d-1(d), attach an exhibit stating the identity of each member of the group.


    See Exhibit I
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    Millennium Management LLC
     
    Signature:/s/ Gil Raviv
    Name/Title:Gil Raviv, Global General Counsel
    Date:08/07/2025
     
    Millennium Group Management LLC
     
    Signature:/s/ Gil Raviv
    Name/Title:Gil Raviv, Global General Counsel
    Date:08/07/2025
     
    Israel A. Englander
     
    Signature:/s/ Israel A. Englander
    Name/Title:Israel A. Englander
    Date:08/07/2025
    Exhibit Information

    Exhibit I: Joint Filing Agreement, dated as of August 7, 2025, by and among Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander.

    Get the next $CC alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CC

    DatePrice TargetRatingAnalyst
    3/27/2025$19.00Neutral → Outperform
    Mizuho
    1/28/2025$27.00Buy
    Truist
    7/9/2024$28.00 → $30.00Neutral → Buy
    UBS
    6/7/2024$25.00Neutral
    Mizuho
    4/9/2024$19.00 → $34.00Underperform → Outperform
    BMO Capital Markets
    3/5/2024$37.00 → $21.00Buy → Neutral
    UBS
    2/29/2024$45.00 → $19.00Outperform → Underperform
    BMO Capital Markets
    12/1/2023$28.00 → $40.00Sector Perform → Outperform
    RBC Capital Mkts
    More analyst ratings

    $CC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Chemours upgraded by Mizuho with a new price target

    Mizuho upgraded Chemours from Neutral to Outperform and set a new price target of $19.00

    3/27/25 8:05:02 AM ET
    $CC
    Major Chemicals
    Industrials

    Truist initiated coverage on Chemours with a new price target

    Truist initiated coverage of Chemours with a rating of Buy and set a new price target of $27.00

    1/28/25 7:09:50 AM ET
    $CC
    Major Chemicals
    Industrials

    Chemours upgraded by UBS with a new price target

    UBS upgraded Chemours from Neutral to Buy and set a new price target of $30.00 from $28.00 previously

    7/9/24 8:13:51 AM ET
    $CC
    Major Chemicals
    Industrials

    $CC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Chemours and SRF Limited Announce Strategic Agreements in India to Support Market Needs for Essential Applications by 2026

    The Chemours Company (Chemours) (NYSE:CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions (TSS), Titanium Technologies (TT), and Advanced Performance Materials (APM), today announced the signing of strategic agreements with SRF Limited (SRF), a diversified, chemical-based multi-business conglomerate headquartered in India. SRF is engaged in the manufacturing of industrial and specialty intermediates, including fluoropolymers. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250819039600/en/ This collaboration strengthens Chemours' global supply chain footprint, bolsters operational flex

    8/19/25 5:00:00 AM ET
    $CC
    Major Chemicals
    Industrials

    Samsung Electronics Successfully Qualifies Chemours' Opteon™ Two-Phase Immersion Cooling Fluid

    Represents a key step in market adoption of Chemours' liquid cooling solution The Chemours Company (Chemours) (NYSE:CC), a global chemistry company, announced the successful qualification of its Opteon™ two-phase immersion cooling fluid by Samsung Electronics. This milestone marks a significant advancement in Opteon™ two-phase immersion cooling adoption, ensuring fluid compatibility and performance with current-generation Samsung Solid State Drive (SSD)—a high-performance storage device. Qualification of this critical server component provides increased certainty to server manufacturers, supporting market adoption and ultimately addressing the cooling and energy demands driven by AI and n

    8/13/25 6:45:00 AM ET
    $CC
    Major Chemicals
    Industrials

    Chemours, DuPont and Corteva Reach Agreement with the State of New Jersey to Comprehensively Resolve All Environmental Claims Including PFAS

    Resolves all environmental claims, including those related to PFAS, across four current and former operating sites and all statewide PFAS claims, including those related to aqueous film forming foam ("AFFF"). Settlement payments over 25 years, with pre-tax net present value of approximately $500 million to be shared by the parties in accordance with existing cost sharing arrangements. Remediation for operations at current and former operating sites will continue in accordance with existing legal requirements. DuPont and Corteva to acquire Chemours' rights to certain insurance proceeds related to PFAS claims for $150 million. The Chemours Company (NYSE:CC), DuPont de Nemours

    8/4/25 6:45:00 AM ET
    $CC
    $CTVA
    $DD
    Major Chemicals
    Industrials
    Farming/Seeds/Milling
    Consumer Staples

    $CC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Accounting Officer Will David covered exercise/tax liability with 2,374 shares, decreasing direct ownership by 9% to 25,190 units (SEC Form 4)

    4 - Chemours Co (0001627223) (Issuer)

    8/14/25 7:53:43 PM ET
    $CC
    Major Chemicals
    Industrials

    President & CEO Dignam Denise bought $49,060 worth of shares (4,068 units at $12.06) (SEC Form 4)

    4 - Chemours Co (0001627223) (Issuer)

    8/12/25 5:12:16 PM ET
    $CC
    Major Chemicals
    Industrials

    Chief Financial Officer Hostetter Shane covered exercise/tax liability with 3,021 shares, decreasing direct ownership by 5% to 57,115 units (SEC Form 4)

    4 - Chemours Co (0001627223) (Issuer)

    8/8/25 4:21:48 PM ET
    $CC
    Major Chemicals
    Industrials

    $CC
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Chemours Company

    SCHEDULE 13G/A - Chemours Co (0001627223) (Subject)

    8/8/25 4:08:39 PM ET
    $CC
    Major Chemicals
    Industrials

    Amendment: SEC Form SCHEDULE 13G/A filed by Chemours Company

    SCHEDULE 13G/A - Chemours Co (0001627223) (Subject)

    8/6/25 11:56:23 AM ET
    $CC
    Major Chemicals
    Industrials

    SEC Form 10-Q filed by Chemours Company

    10-Q - Chemours Co (0001627223) (Filer)

    8/5/25 5:12:10 PM ET
    $CC
    Major Chemicals
    Industrials

    $CC
    Financials

    Live finance-specific insights

    View All

    Chemours Announces Dates for Second Quarter 2025 Earnings Release and Webcast Conference Call

    The Chemours Company ("Chemours" or "the Company") (NYSE:CC) today announced that the Company expects to issue its second quarter 2025 financial results after market on Tuesday, August 5, 2025. The Company expects to hold its conference call to discuss its second quarter 2025 financial results at 8:00 a.m. Eastern Daylight Time on Wednesday, August 6, 2025. The call is open to the public and can be accessed via the webcast information below. Prior to the Company's conference call, management will post additional prepared financial remarks in the "Events and Presentations" section of the Investor Relations section of Chemours' website at investors.chemours.com. Conference Call: Please vi

    7/29/25 4:30:00 PM ET
    $CC
    Major Chemicals
    Industrials

    Chemours Announces Dates for First Quarter 2025 Earnings Release and Webcast Conference Call

    The Chemours Company ("Chemours" or "the Company") (NYSE:CC) today announced that the Company expects to issue its first quarter 2025 financial results after market on Tuesday, May 6, 2025. The Company expects to hold its conference call to discuss its first quarter 2025 financial results at 8:00 a.m. Eastern Daylight Time on Wednesday, May 7, 2025. The call is open to the public and can be accessed via the webcast information below. Conference Call: Please visit investors.chemours.com for a link to the live webcast and to view the accompanying slides. Replay: A webcast replay will be available at investors.chemours.com. About The Chemours Company The Chemours Company (NYSE:CC) is a glo

    4/16/25 4:30:00 PM ET
    $CC
    Major Chemicals
    Industrials

    Chemours Announces First Quarter Dividend

    The Chemours Company ("Chemours") (NYSE:CC) today announced the Board of Directors of Chemours declared a quarterly cash dividend of $0.25 per share on the Company's common stock for the first quarter of 2025. The dividend will be paid on March 14, 2025, to stockholders of record as of the close of business on February 28, 2025. About The Chemours Company The Chemours Company (NYSE:CC) is a global leader in providing industrial and specialty chemicals products for markets, including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and advanced electronics, general industrial, and oil and gas. Through our three businesses – Thermal & Specialized Solut

    2/14/25 4:30:00 PM ET
    $CC
    Major Chemicals
    Industrials

    $CC
    Leadership Updates

    Live Leadership Updates

    View All

    Chemours Appoints Matthew Conti as Chief Human Resources Officer

    Seasoned HR executive supports Chemours' Pathway to Thrive strategy The Chemours Company (Chemours) (NYSE:CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions (TSS), Titanium Technologies (TT), and Advanced Performance Materials (APM), today announced the appointment of Matthew Conti as Chief Human Resources Officer (CHRO), effective June 2. His appointment follows an extensive external search to identify a leader who will drive Chemours' people and culture strategy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250612880421/en/Chemours appoints Matthew Conti as Chief Human Resource

    6/12/25 4:30:00 PM ET
    $CC
    Major Chemicals
    Industrials

    Chemours Appoints Industry Vet Nathan Blom as Vice President of Liquid Cooling Growth Portfolio

    The Chemours Company ("Chemours") (NYSE:CC), a global chemistry company, announced the appointment of Nathan Blom as Vice President of its liquid cooling portfolio, effective June 9, 2025. With Blom's wealth of technology and data center experience, his addition reinforces Chemours' commitment to driving near- and long-term growth in the liquid cooling market. Bringing over two decades of experience in executive leadership, business transformation, and go-to-market strategy across the technology and data center infrastructure sectors, Blom is a strong addition to Chemours leadership. The appointment supports the company's "Pathway to Thrive" strategy, with liquid cooling representing a ke

    6/10/25 6:45:00 AM ET
    $CC
    Major Chemicals
    Industrials

    DoorDash, TKO Group Holdings, Williams-Sonoma and Expand Energy Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600

    NEW YORK, March 7, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, March 24, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. All companies being added to the S&P 100 are more representative of the mega-cap market space. All companies being added to the S&P 500 are more representative of the large-cap market space, all companies being added to the S&P MidCap 400 are more representative of the mid-cap market space, and all companies being added to the S&P

    3/7/25 6:19:00 PM ET
    $ALK
    $AMBC
    $ATI
    Air Freight/Delivery Services
    Consumer Discretionary
    Property-Casualty Insurers
    Finance

    $CC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President & CEO Dignam Denise bought $49,060 worth of shares (4,068 units at $12.06) (SEC Form 4)

    4 - Chemours Co (0001627223) (Issuer)

    8/12/25 5:12:16 PM ET
    $CC
    Major Chemicals
    Industrials

    Officer Gumpel Damian bought $201,376 worth of shares (21,222 units at $9.49), increasing direct ownership by 19% to 131,701 units (SEC Form 4)

    4 - Chemours Co (0001627223) (Issuer)

    6/4/25 8:32:18 PM ET
    $CC
    Major Chemicals
    Industrials

    Chief Financial Officer Hostetter Shane bought $50,196 worth of shares (4,450 units at $11.28), increasing direct ownership by 8% to 59,694 units (SEC Form 4)

    4 - Chemours Co (0001627223) (Issuer)

    5/21/25 5:13:57 PM ET
    $CC
    Major Chemicals
    Industrials

    $CC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Chemours Company

    SC 13G/A - Chemours Co (0001627223) (Subject)

    11/12/24 9:55:16 AM ET
    $CC
    Major Chemicals
    Industrials

    SEC Form SC 13G/A filed by Chemours Company (Amendment)

    SC 13G/A - Chemours Co (0001627223) (Subject)

    2/9/24 8:50:19 AM ET
    $CC
    Major Chemicals
    Industrials

    SEC Form SC 13G/A filed by Chemours Company (Amendment)

    SC 13G/A - Chemours Co (0001627223) (Subject)

    1/24/24 9:46:44 AM ET
    $CC
    Major Chemicals
    Industrials